BofA raised the firm’s price target on Teladoc (TDOC) to $11.50 from $10.50 and keeps a Neutral rating on the shares after the company announced the acquisition of Catapult Health, a provider of virtual preventive care services. While the acquisition is small, it can help Teladoc maintain and grow its relationships with its current customers, says the firm, which slightly increased it multiple to reflect this view.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- M&A News: Teladoc Health (NASDAQ:TDOC) To Buy Catapult Health
- Teladoc call volume above normal and directionally bullish
- Teladoc Health to acquire Catapult Health in all-cash transaction for $65M
- Teladoc price target raised to $12 from $11 at RBC Capital
- Teladoc price target lowered to $10.50 from $11.50 at BofA